Article

Sydney Morning HeraldSydney Morning Herald on 2022-05-21 16:00

‘It’s scary, the thought of not having access’: New anti-depressant considered for PBS

Esketamine nasal spray was approved by Australia’s medical regulator last year, but without a PBS listing it will cost patients more than $3000 for an ...

Related news